Health-Care Delay in Malignant Melanoma: Various Pathways to Diagnosis and Treatment

Table 3

Comparison between primary health-care centers (PHC) and dermatological and other clinic groups (Derm) as related to age, sex, tumor thickness, and type.

	Total	PHCs	Derm	𝑃-value
Age (yrs)
Median	60	58	60.5	0.726^1
≤60 (𝑛 (%))	38 (53.5)	29 (54.7)	9 (50.0)	0.729^2
Sex
Women (𝑛 (%))	53 (74.6)	30 (56.6)	8 (44.4)	0.372^2
Men (𝑛 (%))	18 (25.4)	23 (43.4)	10 (56.6)
Tumor thickness (mm)
Mean/median	1.01/0.75	1.12/0.80	0.70/0.37	0.140^1
>0.70 (𝑛 (%))	36 (50.7)	29 (54.7)	7 (38.9)	0.246^2
Tumor type (𝑛 (%))
SSM	38 (53.5)	28 (52.8)	10 (55.6)	0.360^2
NM	11 (15.5)	10 (18.9)	1 (5.6)
In situ	22 (31.0)	15 (28.3)	7 (38.9)

1Mann-Whitney 𝑈 test. ²Chi-square test. SSM: superficial spreading melanoma, NM: nodular melanoma, PHCs: primary health-care centers, Derm: dermatological and other clinics.